Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series

Transplantation. 2022 Feb 1;106(2):e161-e162. doi: 10.1097/TP.0000000000003991.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Antibody Formation*
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / administration & dosage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Organ Transplantation / adverse effects*
  • RNA, Messenger / genetics
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification
  • Transplant Recipients*
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines
  • RNA, Messenger